$16.24
Progyny is a health information services business based in the US. Progyny shares (PGNY) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $16.18 – a decrease of 2.82% over the previous week. Progyny employs 563 staff and has a trailing 12-month revenue of around $1.1 billion.
Our top picks for where to buy Progyny stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy Progyny stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PGNY. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Progyny stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Progyny stock price (NASDAQ: PGNY)
Use our graph to track the performance of PGNY stocks over time.Progyny shares at a glance
Latest market close | $16.18 |
---|---|
52-week range | $13.93 - $42.08 |
50-day moving average | $22.75 |
200-day moving average | $30.91 |
Wall St. target price | $23.71 |
PE ratio | 26.6032 |
Dividend yield | N/A |
Earnings per share (TTM) | $0.63 |
Is it a good time to buy Progyny stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Progyny price performance over time
Historical closes compared with the close of $16.18 from 2024-10-01
1 week (2024-09-25) | -2.82% |
---|---|
1 month (2024-08-30) | -31.12% |
3 months (2024-07-02) | -42.89% |
6 months (2024-04-02) | -54.64% |
1 year (2023-10-02) | -52.30% |
---|---|
2 years (2022-09-30) | -56.34% |
3 years (2021-10-01) | 57.21 |
5 years (2019-09-28) | N/A |
Is Progyny stock undervalued or overvalued?
Valuing Progyny stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Progyny's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Progyny's P/E ratio
Progyny's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, Progyny shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Progyny's EBITDA
Progyny's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $73.9 million.
The EBITDA is a measure of a Progyny's overall financial performance and is widely used to measure a its profitability.
Progyny financials
Revenue TTM | $1.1 billion |
---|---|
Operating margin TTM | 6.8% |
Gross profit TTM | $167.3 million |
Return on assets TTM | 6.45% |
Return on equity TTM | 13.56% |
Profit margin | 5.54% |
Book value | $5.03 |
Market Capitalization | $1.5 billion |
TTM: trailing 12 months
Progyny share dividends
We're not expecting Progyny to pay a dividend over the next 12 months.
Progyny share price volatility
Over the last 12 months, Progyny's shares have ranged in value from as little as $13.93 up to $42.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Progyny's is 1.443. This would suggest that Progyny's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Progyny overview
Progyny, Inc. , a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc.
Frequently asked questions
What percentage of Progyny is owned by insiders or institutions?Currently 6.575% of Progyny shares are held by insiders and 107.223% by institutions. How many people work for Progyny?
Latest data suggests 563 work at Progyny. When does the fiscal year end for Progyny?
Progyny's fiscal year ends in December. Where is Progyny based?
Progyny's address is: 1359 Broadway, New York, NY, United States, 10018 What is Progyny's ISIN number?
Progyny's international securities identification number is: US74340E1038 What is Progyny's CUSIP number?
Progyny's Committee on Uniform Securities Identification Procedures number is: 74340E103
More guides on Finder
-
How to Trade Options on Sofi®: A Beginner’s Guide
Step 1: Open and fund your account, Step 2: Enable options trading, Step 3: Select and trade options, Step 4: Closing options trades.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Call options explained
Learn the basics of call options: what they are, how they work and examples.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 best stock apps of 2024 to elevate your mobile trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
Zacks Trade review 2024
What to expect when you sign up for a Zacks Trade brokerage account.
Ask a question